Chief Executive Officer

NPF Expands Seal of Recognition to FDA-approved Treatments and Awards its First to Arcutis' ZORYVE® (roflumilast)

Arcutis to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

Arcutis Biotherapeutics (ARQT) ZORYVE Topical Foam 0.3% Approved by U.S. FDA for the Treatment of Plaque Psoriasis in Adults and Adolescents Ages 12 and Older

Arcutis’ ZORYVE® (roflumilast) Topical Foam 0.3% Approved by U.S. FDA for the Treatment of Plaque Psoriasis in Adults and Adolescents Ages 12 and Older

Molecular Diagnostics Intern

Acutis Diagnostics is seeking motivated and enthusiastic interns to join their clinical molecular laboratory team. The unpaid internship provides hands-on experience in molecular diagnostics, focusing on urinary tract infection testing, through a structured program that includes training and collaboration with experienced technologists.

Sign up with Google

Sign in with Google